The Latest Breaking News on Pharma

Abortion rights advocates say that if the FDA withdraws its mifepristone approval, it would essentially result in a national ban.

Activists hail the move as ‘a step in the right direction’

Editorial: The government faces a crisis in a part of the state where voters don’t fully trust it

Among the top stocks to watch, pharmaceutical leader AstraZeneca is retaking its latest buy point despite Tuesday's stock market weakness.

Formerly known as Aesica, the Northumberland firm was acquired by China's pharma giant Pharmaron a year ago

Biopharmaceutical company Pfizer (PFE) is committed to executing its strategies to deliver breakthroughs to patients worldwide. The company saw a solid operational performance in the last reported quarter and raised its full-year 2022 outlook. Given PFE’s strong fundamentals and reliable dividends, this stock could be an ideal long-term investment. Read…

The substantially busy time is down to an "unprecedented combination of very high levels of flu, Covid-19, and other respiratory illnesses in the community"

The BMA called the results 'worrying'

Her death is being investigated as possible suicide